Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Regulatory News (IXI)

Share Price Information for Ixico (IXI)

Share Price is delayed by 15 minutes
Get Live Data
8.65    0.00 (0.00%)
Bid:
8.30
Ask:
9.00
Spread: 0.70 (8.434%)
Market Cap: £18.86m
IXI Live PriceLast checked at - London Stock Exchange

Intraday Ixico Share Chart

Annual Information Update

7 Feb 2011 12:18

RNS Number : 7974A
Phytopharm PLC
07 February 2011
 

Phytopharm plc

 

Annual Information Update

 

Phytopharm plc (the Company) announces that, in accordance with the requirements of Prospectus Rule 5.2 issued by the Financial Services Authority, and following publication of the Annual Report on 31 January 2011, the following information has been published or made available to the public between 14 December 2009 and 7 February 2011 inclusive, in compliance with laws and rules dealing with the regulation of securities, issuers of securities and securities markets.

1. Announcements made via the Regulatory Information Service ("RIS")

All the announcements listed below were published through a regulatory information service on the dates indicated. Copies can be obtained from the London Stock Exchange website, http://www.londonstockexchange.com or from the Company's website www.phytopharm.com

Date of publication

Title

1 February 2011

Total voting rights

1 February 2011

Annual Report 2010 and notice of 2011 AGM

19 January 2011

Director/PDMR shareholding

19 January 2011

Director/PDMR shareholding

14 January 2011

Holdings in Company

10 January 2011

Holdings in Company

7 January 2011

Block Listing Application

4 January 2011

Total voting rights

21 December 2010

Director/PDMR shareholding

21 December 2010

Director/PDMR shareholding

14 December 2010

Block Listing application

30 November 2010

Final results

17 November 2010

Research update

3 November 2010

Block listing interim review

1 November 2010

Preliminary results - change of date

1 November 2010

Notice of preliminary results

29 September 2010

Presentation at scientific conference

18 August 2010

Interim management statement

22 July 2010

Director/PDMR shareholding

22 July 2010

Director/PDMR shareholding

5 July 2010

Change of registered office

21 June 2010

Appointment of Chief Executive Officer

14 June 2010

Regulatory approval to begin Cogane™ Phase II trial

24 May 2010

Half yearly report

19 May 2010

Notice of results

4 May 2010

Block listing interim review

1 April 2010

Director/PDMR shareholding

1 April 2010

Director/PDMR shareholding

1 April 2010

Director/PDMR shareholding

31 March 2010

Results of Annual General Meeting

2 March 2010

Notice of Annual General Meeting

11 February 2010

Interim Management Statement

15 January 2010

Appointment of R & D Director

5 January 2010

Holding in company

4 January 2010

Total voting rights

31 December 2009

Director/PDMR shareholding

31 December 2009

Director/PDMR shareholding

31 December 2009

Director/PDMR shareholding

31 December 2009

Director/PDMR shareholding

29 December 2009

GM results

22 December 2009

Open Offer results

15 December 2009

Correction to Form of Proxy

15 December 2009

Annual Information update

14 December 2009

Presents data at XVIII WFN Congress

2. Documents published or sent to Shareholders, filed with the UK Listing Authority or submitted to the FSA including those filed with the National Storage Mechanism:

Date of publication

Title

1 February 2011

Notice of 2011 Annual General Meeting

1 February 2011

Annual Report 2010

2 June 2010

Interim Report 2010

31 March 2010

AGM resolutions

2 March2010

Notice of Annual General Meeting

30 December 2009

General Meeting resolutions

The 2010 Interim and 2010 Annual reports are available on the Company's website www.phytopharm.com

3. Documents filed at Companies House

The following documents were files at Companies House. Copies of these documents can be obtained from the Companies House website at www.companieshouse.gov.uk, or Companies House, Crown Way, Cardiff CF14 3UZ

Date of Publication

Title

25 January 2011

Form SH01 Return of allotment of shares on 14 January 2011

5 January 2011

Form SH01 Return of allotment of shares on 16 December 2010

16 December 2010

Form AR01 Annual return

6 July 2010

Form AP01 Appointment of director

6 July 2010

Form AD01 change of registered office address

31 March 2010

Articles of Association approved by shareholders on 30 march 2010

31 March 2010

Annual General Meeting resolutions

25 January 2010

Form AP01 Appointment of director

4 January 2010

Form SH01 Return of allotment of shares on 29 December 2009

Copies of all documents referred to above are also available for inspection at the Company's registered office (Lakeview House, 2 Lakeview Court, Ermine Business Park, Huntingdon, Cambs PE29 6UA, United Kingdom) during normal business hours or by written request from the Company Secretary.

This annual information is required by, and is being made pursuant to, Article 10 of the Prospectus Directive as implemented by the UK Prospectus Rule 5.2 and not for any other purpose and neither the Company, nor any other person, takes any responsibility for, or makes any representation, express of implied, as to the accuracy or completeness of, the information which it contains. The information is not necessarily up to date as at the date of this annual information update and the Company does not undertake any obligation to update any such information in the future. Neither this annual information update, not referred to in it, constitutes, by virtue of this communication, an offer of securities addressed to any person and it should not be relied on by any person.

For further information, please contact:

Zoe McGowan, Company Secretary

Phytopharm plc Tel No: +44 (0)1480 437697

Further information about Phytopharm can be found on the Company's website www.phytopharm.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AIUEAAAXEFAFEFF
Date   Source Headline
4th Apr 20167:00 amRNSConsortium and Five Year Contract
31st Mar 20167:00 amRNSReal world study of Digital Biomarkers
31st Mar 20167:00 amRNSGrant of Awards to Directors
30th Mar 20167:00 amRNSNHS emergency and out-of-hours services contract
9th Mar 20169:30 amRNSEuropean research to tackle dementia
3rd Mar 20167:00 amRNSMehealth® used in American Academy of Pediatrics
1st Mar 201610:35 amRNSDirector/PDMR Shareholding
5th Feb 20167:00 amRNSDirector/PDMR Shareholding
4th Feb 20167:00 amRNSDirector/PDMR Shareholding
29th Jan 201610:45 amRNSResult of AGM
29th Jan 20167:00 amRNSAGM Statement
22nd Jan 20167:00 amRNSSelected for two NHS Innovation Test Beds
21st Jan 20167:00 amRNSMyBrainBook wins Regional Business Award
18th Jan 20167:00 amRNSFour contracts awarded worth over £3.0m
7th Jan 20167:00 amRNSFinancial Results for the year ended 30 Sept 2015
21st Dec 20152:03 pmRNSUpdate on Issued Share Capital
7th Dec 201510:04 amRNSResult of General Meeting
18th Nov 20153:45 pmRNSPublication of Circular
18th Nov 20157:00 amRNSProposed acquisition of Optimal Medicine & placing
2nd Nov 20153:38 pmRNSTotal Voting Rights
19th Oct 20157:00 amRNSPre-Close Trading Update
12th Oct 20151:16 pmRNSAdditional Listing
9th Oct 20157:00 amRNSCollaboration with leading pharmaceutical co in MS
2nd Oct 201511:18 amRNSExercise of Share Options
28th Aug 20157:00 amRNSIXICO awarded significant long-term contract
29th Jun 20157:00 amRNSVirtualScopics Alliance Update
25th Jun 20151:21 pmRNSHolding(s) in Company
26th May 20157:01 amRNSRelease of beta version of MyBrainBook®
12th May 20157:00 amRNSLaunch of UK Government funded project
30th Apr 20157:49 amRNSLaunch of dementia care digital platform
24th Apr 20157:00 amRNSNew contract in Huntington's disease
11th Mar 20157:00 amRNSVirtualScopics, IXICO and Micron in collaboration
6th Mar 201511:38 amRNSResult of AGM
10th Feb 20154:25 pmRNSReplacement - Financial Results
10th Feb 20157:00 amRNSResults for the 16 month period ended 30 Sept 2014
16th Jan 20157:00 amRNSIXICO selected as EPAD imaging analysis partner
16th Dec 20147:00 amRNSLicense of TrialTracker to VirtualScopics
26th Nov 20147:00 amRNSAnnouncement of enhanced contracts
29th Oct 20147:30 amRNSGrant of Awards to Directors
17th Sep 20147:00 amRNSAppointment of Chief Financial Officer
7th Aug 20147:00 amRNSAdditional Listing
31st Jul 20144:19 pmRNSHolding(s) in Company
21st Jul 20144:33 pmRNSDirector/PDMR Shareholding
18th Jul 20147:00 amRNSTrading Update
19th Jun 20147:00 amRNSCollaboration with the MRC for dementia research
6th Jun 20147:00 amRNSHalf Yearly Report
22nd May 20147:00 amRNSTwo contracts in Huntington's disease awarded
30th Apr 20142:58 pmRNSHolding(s) in Company
16th Apr 20147:00 amRNSIXICO plc announces SBRI Healthcare contract
20th Mar 201412:41 pmRNSResults of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.